Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Lung Carcinoma”

205 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 205 results

Testing effectiveness (Phase 2)Study completedNCT01844791
What this trial is testing

An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Oncozyme Pharma Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT06515990
What this trial is testing

DM005 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and NeckSolid Carcinoma
Doma Biopharmaceutical（Suzhou）Co., Ltd. 208
Testing effectiveness (Phase 2)Study completedNCT00252746
What this trial is testing

ZD6474 Phase IIa Dose Finding Multicentre Study

Who this might be right for
Non Small Cell Lung Carcinoma
Genzyme, a Sanofi Company 53
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Ended earlyNCT00863512
What this trial is testing

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Ended earlyNCT03995667
What this trial is testing

Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaStage I Lung Cancer AJCC v8+14 more
OHSU Knight Cancer Institute 3
Not applicableActive Not RecruitingNCT03686007
What this trial is testing

Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients

Who this might be right for
CaregiverStage I Lung Cancer AJCC v7Stage IA Lung Cancer AJCC v7+7 more
City of Hope Medical Center 380
Not applicableNot Yet RecruitingNCT06580665
What this trial is testing

Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Chest Hospital 134
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472478
What this trial is testing

Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)

Who this might be right for
Lung Cancer (NSCLC)KRAS G12C Lung Cancer
Guangdong Provincial People's Hospital 32
Early research (Phase 1)Ended earlyNCT00856427
What this trial is testing

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

Who this might be right for
Lung Cancer
Virginia Commonwealth University 6
Testing effectiveness (Phase 2)Study completedNCT00923312
What this trial is testing

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
CureVac 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05118854
What this trial is testing

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT03654833
What this trial is testing

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University of Leicester 186
Testing effectiveness (Phase 2)UnknownNCT06065813
What this trial is testing

Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNeoadjuvant TherapyRadiotherapy+1 more
Northern Jiangsu People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00034541
What this trial is testing

Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 32
Not applicableStudy completedNCT03091816
What this trial is testing

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+1 more
University of Southern California 15
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT03304093
What this trial is testing

Immunotherapy by Nivolumab for HIV+ Patients

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Stage IIIBHIV/AIDS
Intergroupe Francophone de Cancerologie Thoracique 30
Testing effectiveness (Phase 2)Ended earlyNCT04638582
What this trial is testing

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
McGill University Health Centre/Research Institute of the McGill University Health Centre 6
Next Page